Sustained Release Multiple Unit Dosage Form for the Oral Day Delivery of Dexketoprofen Trometamol

Journal Title: Open Access Journal of Pharmaceutical Research - Year 2017, Vol 1, Issue 3

Abstract

The aim of this study was to prepare sustained release multiple unit dosage form (MUDF) for the oral day delivery of the frequently administered and the highly water soluble drug, dexketoprofen trometamol (DT). The drug was encapsulated into Eudragit RS100 microspheres using emulsification solvent evaporation technique. A D-optimal design was used to determine the effect of amount of polymer (X1), the percentage of hydrophobic plasticizer (X2), the percentage of hydrophilic plasticizer (X3), and stirring rate (X4), on the % entrapment efficiency (Y1), amount of drug released at 1h (Y2), 4h (Y3), and 8 h (Y4). The optimized formulation was prepared using 1.39 g Eudragit, 0.063 g Dibutyl phthalate (DBP), 0.093 g Polyethylene Glycol 400 (PEG 400) and processed using stirring rate of 683 rpm. The optimized microspheres were evaluated by Scanning Electron Microscopy (SEM), Differential Scanning Calorimetry (DSC), and Xray Diffraction (XRD). Results of the optimized formula showed that the microspheres were spherical with a rough surface and a particle size of 32±1.41 µm, with entrapment efficiency 76.0±1.76%. The amount of drug released was 33.7±0.82%, 60.2±0.05%, and 75.1±1.84%, at 1, 4, and 8 h, respectively. Complete drug release was achieved after 16 h. The sustained release pattern of DT for up to 16 h with an acceptable initial release suggests that the developed MUDF may be useful for oral day delivery of the highly soluble and frequently administered drug such as DT.

Authors and Affiliations

Sweed NM, Basalious EB and Nour SA*

Keywords

Related Articles

Preliminary Phytochemical and Acute Toxicity Studies of Methanol Leaf Extract of Acioa Barteri

Acioa barteri plant has higher medicinal value and can be extensively studied to extract the natural compounds which are beneficial to human beings and that could be commercialized for higher production than using synthe...

No to the Herd Immunity against Novel Coronavirus (SARS-Cov-2) without Vaccination

The sheer importance of the herd’s immunity in protecting societies from the burden of contagious diseases and in providing opportunities for survival and continuity has not hidden after those societies were threatened,...

Diclofenac Sodium Loaded Nanosized Ethosomes: An Investigation on Z-Average, Polydispersity and Stability

Diclofenac sodium is a non-steroidal anti-inflammatory drug (NSAID). Oral therapy with NSAID is always associated with several side effects such as gastric bleeding, and ulceration. The purpose of this work was to explor...

Mini Review: Pharmacokinetics Changes During Childhood, Old Age and Pregnancy

In the different stages of life, various anatomical and physiological changes occur and can influence the responses to drugs, due to pharmacokinetic processes also change with age. In this context, it is important to ana...

Stability and Stabilization of Pabialgin (Cibalgin) Liquid Preparation

Shelf-life time was supposed to be determined for active principles of original Pabialgin® (Cibalgin®) drops (allobarbital, aminophenazone) and for its stabilized liquid formulation using accelerated testing at elevated...

Download PDF file
  • EP ID EP745763
  • DOI 10.23880/oajpr-16000114
  • Views 22
  • Downloads 0

How To Cite

Sweed NM, Basalious EB and Nour SA* (2017). Sustained Release Multiple Unit Dosage Form for the Oral Day Delivery of Dexketoprofen Trometamol. Open Access Journal of Pharmaceutical Research, 1(3), -. https://europub.co.uk/articles/-A-745763